Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test
Global, exclusive, direct-to-consumer sales and marketing agreement for COVID-19 self-testing. [...]
Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins
CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house [...]
Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19
Affimer reagents discovered that block the virus’ interaction with ACE2 [...]
Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific
CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA, 12 May, [...]
Avacta Ships SARS-COV-2 Affimer Reagents to Cytiva and Adeptrix
Cambridge and Wetherby, UK, 11 May 2020: Avacta Group plc (AIM: [...]
British companies Mologic and BioSure partner on COVID-19 Antibody Self-Test
BioSure joins forces with Mologic on production of COVID-19 Antibody [...]
AI VIVO seeks collaboration partners to progress top-ranked COVID-19 therapeutic candidates
41 of the candidate drugs from AI VIVO’s top-ranked list [...]
IONTAS announces a new collaboration to identify novel immunotherapy targets
Antibody discovery agreement will support development of new therapeutics for [...]
Bio-Rad Launches Anti-Certolizumab Pegol Antibodies
HERCULES, Calif.–May 05, 2020–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), [...]
Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix
Second partnership to exploit the recently generated Affimer binders to [...]